mRNA |
SB-525334 |
CTRPv2 |
pan-cancer |
AAC |
0.11 |
0.004 |
mRNA |
epigallocatechin-3-monogallate |
CTRPv2 |
pan-cancer |
AAC |
0.1 |
0.006 |
mRNA |
Doxorubicin |
gCSI |
pan-cancer |
AAC |
-0.14 |
0.006 |
mRNA |
tretinoin:navitoclax (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.095 |
0.007 |
mRNA |
Obatoclax Mesylate |
CTRPv2 |
pan-cancer |
AAC |
-0.091 |
0.008 |
mRNA |
BRD4132 |
CTRPv2 |
pan-cancer |
AAC |
-0.1 |
0.009 |
mRNA |
BRD-K45681478 |
CTRPv2 |
pan-cancer |
AAC |
0.095 |
0.01 |
mRNA |
doxorubicin:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.084 |
0.01 |
mRNA |
L-685458 |
CCLE |
pan-cancer |
AAC |
-0.11 |
0.01 |
mRNA |
vorinostat:navitoclax (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.089 |
0.01 |